title: Porphyria cutanea tarda associated with methotrexate therapy.
abstract: A 69-year-old lady with RA developed porphyria cutanea tarda 2 weeks following initiation of methotrexate therapy. The clinical and laboratory features are described.
authors.affiliation: Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath.
authors.forename: T
authors.initials: T
authors.lastname: O'Neill
authors.forename: J
authors.initials: J
authors.lastname: Simpson
authors.forename: S J
authors.initials: SJ
authors.lastname: Smyth
authors.forename: C
authors.initials: C
authors.lastname: Lovell
authors.forename: A
authors.initials: A
authors.lastname: Calin
mesh_terms: D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D017119:Porphyria Cutanea Tarda / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology
chemical_list: D008727:Methotrexate